Form D · Biotechnology
CATALYST BIOSCIENCES INC
South San Fransicso, CA · CIK 0001270381
Offering snapshot reported Jul 13, 2015 · SEC filing
- Reported sold
- $1.89M Offering amount: $2M
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 29, 2015 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$1,000,000 → $1,890,938
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 13, 2015 | Amendment | $1,890,938 | $890,938vs Jun 11, 2015 | 10 | SEC filing |
| Jun 11, 2015 | Initial | $1,000,000 | No comparison | 10 | SEC filing |
| Feb 3, 2015 | Initial | $3,224,993 | No comparison | 11 | SEC filing |
| Apr 23, 2014 | Initial | $5,009,841 | No comparison | 18 | SEC filing |
| Aug 20, 2013 | Initial | $400,004 | No comparison | 11 | SEC filing |
| Sep 25, 2012 | Initial | $13,407,658 | No comparison | 21 | SEC filing |
| Dec 8, 2008 | Initial | $40,399,998 | No comparison | Not reported | SEC filing |
| Dec 17, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Feb 17, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-241558
Source: Form D, filed Jul 13, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Steven Burrill | Director |
| Steve Burrill | Director |
| Ralph Christoffersen | Director |
| Jeff Himawan | Director |
| Augustine Lawlor | Director |
| Todd Lorenz | Executive |
| Edwin Madison | Executive |
| Fletcher Payne | Executive |
| Michael Powell | Director |
| Barry Selick | Director |
| Harold Selick | Director |
| Nassim Usman | Director, Executive |
| Erik Wiberg | Executive |
| Asish Xavier | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
260 Littlefield Avenue
South San Fransicso, CA, 94080
South San Fransicso, CA, 94080